Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Aditxt, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 10 | 8 | −2 |
| Shares | 18.3K | 17.0K | −1.34K (−7.3%) |
| Value | $62.2K | $23.4K | −$38.8K (−62.4%) |
New holders (1)
Institutions that held Aditxt, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 13 | $18 | 0.00% |
Sold out (3)
Institutions that held Aditxt, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Natixis | 250 | $780 |
| Wells Fargo & Company | 13 | $44 |
| FMR LLC | 1 | $3 |